Global Avenanthramides Market

Avenanthramides Market Summary, Size & Emerging Trends

According to Decision Advisor, The Global Avenanthramides Market Size is Expected to Grow from USD 131.3 Million in 2024 to USD 345.6 Million by 2035, at a CAGR of 9.2% during the forecast period 2025-2035. Increasing awareness of the antioxidant and anti-inflammatory properties of avenanthramides is a key driving factor for the market.

Key Market Insights

• Asia Pacific is expected to account for the largest share in the avenanthramides market during the forecast period.
• In terms of product, the natural avenanthramides segment dominated in terms of revenue during the forecast period.
• In terms of end-use, the personal care & cosmetics segment accounted for the largest revenue share in the global avenanthramides market during the forecast period.

Global Market Forecast and Revenue Outlook

• 2024 Market Size: USD 131.3 Million
• 2035 Projected Market Size: USD 345.6 Million
• CAGR (2025-2035): 9.2%
• Asia Pacific: Largest market in 2024
• North America: Fastest growing market

Avenanthramides Market

The avenanthramides market centers on the production and application of a group of naturally occurring phenolic compounds found predominantly in oats, known for their potent antioxidant and anti-inflammatory effects. These compounds are increasingly utilized in personal care, pharmaceuticals, and animal health industries to promote skin health, reduce inflammation, and enhance immune response. Growing consumer preference for natural and clean-label ingredients is boosting demand for natural avenanthramides. Government initiatives supporting sustainable agriculture and natural product development are further propelling market growth. Technological advancements in extraction and synthesis methods are enabling scalable production, improving cost efficiency and product quality.

Avenanthramides Market Trends

• Rising consumer demand for natural and organic personal care products incorporating avenanthramides.
• Innovations in synthetic avenanthramides production enhancing purity and cost-effectiveness.
• Increased adoption in pharmaceutical formulations for anti-inflammatory and dermatological treatments.

Avenanthramides Market Dynamics

Driving Factors: Growing preference for natural antioxidants in personal care and pharmaceutical products

Key growth factors include increasing consumer awareness about skin protection, anti-aging, and health benefits of avenanthramides. The surge in demand for natural ingredients in cosmetics and animal health products further supports market expansion. Additionally, the pharmaceutical sector is exploring avenanthramides for potential therapeutic applications, creating new opportunities. Regulatory support for natural and sustainable products enhances market credibility and adoption.

Restrain Factors: High extraction costs and limited availability of raw materials

Challenges include the high cost and complexity of extracting natural avenanthramides from oats and other sources, which limits large-scale production. The availability of substitute antioxidants and synthetic alternatives may also restrict market growth. Furthermore, stringent regulatory requirements for novel ingredients in pharmaceuticals and cosmetics can delay product launches and increase development costs.

Opportunity: Advancements in biotechnology for synthetic production

Opportunities arise from biotechnological innovations enabling efficient synthetic production of avenanthramides with consistent quality and at lower costs. Expanding applications in animal health, especially as natural alternatives to antibiotics and growth promoters, represent significant growth potential. Emerging markets with rising demand for natural health and beauty products offer untapped opportunities.

Challenges: Regulatory hurdles and competition from alternative antioxidants

Compliance with evolving regulations on natural ingredients and health claims poses challenges for manufacturers. Competition from other well-established antioxidants like vitamin E, resveratrol, and flavonoids may limit market share. Supply chain disruptions in raw material sourcing can affect product availability and pricing.

Global Avenanthramides Market Ecosystem Analysis

The global avenanthramides market ecosystem comprises raw material suppliers (mainly oat producers), extraction and synthesis companies, manufacturers in personal care, pharmaceutical, and animal health industries, and distributors. Key players focus on optimizing extraction processes and developing synthetic alternatives to meet growing demand. Regulatory agencies influence product approvals and market entry, emphasizing safety and efficacy. The ecosystem’s growth depends on balancing supply chain stability, technological innovation, and regulatory compliance.

Global Avenanthramides Market, By Product

What key advantages helped the natural avenanthramides segment outperform others in 2024?

The natural avenanthramides segment dominated the market in 2024 primarily due to its strong demand driven by its well-known antioxidant, anti-inflammatory, and skin-soothing properties. These benefits made it highly preferred in various industries such as cosmetics and pharmaceuticals, contributing to approximately 65% of the total market share. Additionally, growing consumer awareness and preference for natural and clean-label ingredients further fueled the segment’s revenue growth. The natural origin of avenanthramides, combined with increasing research supporting its efficacy, provided it with a significant competitive edge over synthetic alternatives, ultimately making it the top choice and market leader during the forecast period.

How did the synthetic avenanthramides segment secure a stable market share in 2024?

The synthetic avenanthramides segment held about 35% of the market share in 2024 due to its consistent availability, cost-effectiveness, and ability to meet large-scale production demands. Synthetic variants offered greater control over purity and quality, which appealed to manufacturers requiring standardized ingredients for various applications. Furthermore, advancements in synthetic production processes helped improve efficiency and scalability, supporting the segment’s stable market presence. While natural avenanthramides led the market, the synthetic segment’s affordability and reliable supply ensured it remained a vital and competitive choice for many industries during the forecast period.

Global Avenanthramides Market, By End-use

Why was the personal care & cosmetics segment preferred over other segments in 2024?

The personal care & cosmetics segment accounted for the largest revenue share, approximately 55% of the global avenanthramides market in 2024, driven primarily by the increasing consumer demand for natural and effective skincare ingredients. Avenanthramides are widely recognized for their anti-inflammatory, antioxidant, and soothing properties, making them highly sought-after in formulations for sensitive skin and anti-aging products. Rising awareness about skin health and the preference for clean-label, naturally derived ingredients further propelled growth in this segment. Additionally, innovations in product formulations and expanding personal care product lines contributed to the segment’s dominant revenue share and competitive advantage during the forecast period.

What made the pharmaceuticals segment a major contributor to market revenue in 2024?

The pharmaceuticals segment captured around 30% of the avenanthramides market share in 2024, largely due to the growing recognition of avenanthramides' therapeutic properties, including their anti-inflammatory, antioxidant, and antipruritic effects. These bioactive compounds have shown promise in treating skin conditions such as eczema, dermatitis, and itching, making them valuable in topical and dermatological drug formulations. Increasing R&D investments and clinical interest in plant-based actives also supported their integration into pharmaceutical products. The segment benefited from the rising demand for natural alternatives to synthetic drugs, helping it secure a strong and steady share of the market during the forecast period.

Asia Pacific is expected to account for the largest share of approximately 42% of the global avenanthramides market in 2024.

This dominance is driven by rising consumer demand for natural personal care and cosmetic products, particularly in emerging economies such as China, India, and Japan. The region is experiencing rapid industrialization, increasing urbanization, and growing disposable incomes, which are boosting demand for premium, plant-based skincare and pharmaceutical products. Additionally, government support for natural ingredient-based healthcare products and the expansion of local manufacturing capacity further strengthen the region’s market position.

India is emerging as one of the fastest-growing markets for avenanthramides in the Asia Pacific region, with a projected CAGR of approximately 11.2% during the forecast period

This growth is driven by rising awareness of natural and herbal products, increasing demand for plant-based skincare solutions, and the expansion of the domestic pharmaceutical sector. The Indian personal care industry is witnessing a significant shift toward clean-label, Ayurveda-inspired, and natural ingredient-based products a trend that directly supports the demand for avenanthramides. Additionally, the growing middle class, improved urban healthcare infrastructure, and government initiatives supporting Make in India and nutraceutical research are creating favorable conditions for both local production and import of avenanthramides.

North America is projected to register the fastest CAGR of approximately 9.8% during the forecast period.

The region benefits from a mature personal care industry, robust pharmaceutical R&D infrastructure, and high consumer awareness regarding the benefits of antioxidant-rich formulations. The United States is a key contributor, leading in product innovation, commercial-scale synthetic production, and the development of avenanthramides-based therapeutic and skincare solutions. Strong regulatory support for natural ingredients and increasing investments in advanced manufacturing processes are expected to further accelerate growth in this region.

The United States is the largest contributor to the North American avenanthramides market.

It is also expected to continue leading in innovation, application development, and commercialization of avenanthramides throughout the forecast period. This dominance is supported by the presence of leading pharmaceutical and cosmetic companies, strong consumer preference for natural and scientifically backed ingredients, and an advanced R&D ecosystem. The U.S. market is particularly active in developing synthetic avenanthramides through biotechnology and green chemistry processes to ensure scalability and cost-efficiency.

WORLDWIDE TOP KEY PLAYERS IN THE AVENANTHRAMIDES MARKET INCLUDE

• Oat Cosmetics
• Ceapro Inc.
• BioActor BV
• NutriScience Innovations LLC
• Jiangsu Tiansheng Pharmaceutical Co., Ltd.
• Naturalin Bio-Resources Co., Ltd.
• DKSH Holding Ltd.
• Carrubba Inc.
• Sabinsa Corporation
• BASF SE
• Others

Product Launches in Avenanthramides Market

• In May 2024, Sarepta Therapeutics achieved a significant milestone with the FDA approval of its next-generation gene therapy for Duchenne Muscular Dystrophy (DMD). This approval marks a major advancement in the treatment options available for DMD, a rare and progressive muscle-wasting disorder. By expanding its product pipeline with this innovative therapy, Sarepta has reinforced its leadership position in the rare musculoskeletal disorder segment. The new gene therapy leverages cutting-edge technology designed to improve efficacy and safety, offering renewed hope for patients and caregivers.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decision Advisor has segmented the avenanthramides market based on the below-mentioned segments: 

Global Avenanthramides Market, By Product

• Natural
• Synthetic

Global Avenanthramides Market, By End-use

• Personal Care & Cosmetics
• Pharmaceuticals
• Animal Health

Global Avenanthramides Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

FAQs

Q: What are the main drivers of growth in the Avenanthramides Market?
A: Key drivers include rising consumer preference for natural antioxidants, increasing awareness of skin health and anti-inflammatory benefits, and growth in personal care and pharmaceutical industries.

Q: What challenges are limiting the adoption of avenanthramides?
A: High extraction costs, limited raw material availability, regulatory hurdles, and competition from alternative antioxidants pose challenges to market growth.

Q: What opportunities exist for the avenanthramides market?
A: Advancements in biotechnology for synthetic production, expanding applications in animal health, and growing demand in emerging markets present significant growth opportunities.

Q: How is the synthetic avenanthramides segment performing in the market?
A: The synthetic segment holds around 35% market share in 2024, valued for cost-effectiveness, scalability, and controlled purity.

Q: How does Asia Pacific compare to North America in terms of market growth?
A: Asia Pacific leads in market size due to growing consumer demand and government support, while North America leads in growth rate owing to strong R&D infrastructure and innovation.

Q: What recent product innovations have impacted the market?
A: Notably, Sarepta Therapeutics received FDA approval for a gene therapy in May 2024, reflecting advancements in therapeutic applications, although not directly avenanthramides-related, this highlights the sector’s innovation environment.

Q: What are the latest trends in the Avenanthramides Market?
A: Trends include rising demand for natural and organic personal care products, innovation in synthetic avenanthramides production, and increased pharmaceutical applications.

Q: What is the long-term outlook (2025–2035) for the Avenanthramides Market?
A: The market is expected to maintain robust growth driven by increasing consumer awareness, technological advancements, and expanding applications across personal care, pharmaceuticals, and animal health industries.